Vitrafy Life Sciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	26.1	19.52	6.41	1.72	0.96
Short-Term Investments	-	10.12	0.04	0.04	0.02
Cash & Short-Term Investments	26.1	29.65	6.45	1.76	0.98
Cash Growth	-11.96%	359.48%	266.56%	78.74%	-
Accounts Receivable	1.2	0.06	0.03	0.03	-
Other Receivables	-	1.55	2.17	2.11	1.94
Receivables	1.2	1.61	2.2	2.14	1.94
Prepaid Expenses	-	-	0.38	-	-
Other Current Assets	15.08	-	-	-	0.56
Total Current Assets	42.38	31.25	9.03	3.9	3.49
Property, Plant & Equipment	0.84	0.59	0.75	1.03	0.88
Total Assets	43.21	31.84	9.78	4.93	4.37
Accounts Payable	1.36	0.56	0.27	0.44	0.24
Accrued Expenses	0.36	0.43	0.43	0.32	0.23
Short-Term Debt	-	-	22.86	8.55	7.5
Current Portion of Leases	0.06	0.09	0.08	0.09	0.07
Current Unearned Revenue	-	1.43	-	-	-
Other Current Liabilities	-	0.21	10.31	9.55	3.23
Total Current Liabilities	1.78	2.72	33.95	18.95	11.26
Long-Term Leases	0.24	0.3	0.39	0.54	0.34
Pension & Post-Retirement Benefits	0.08	0.05	0.03	0.07	0.04
Total Liabilities	2.1	3.08	34.38	19.56	11.64
Common Stock	117.66	89.69	5.19	4.92	4.83
Retained Earnings	-76.55	-60.92	-29.79	-20.23	-12.42
Comprehensive Income & Other	-	-	-	0.68	0.32
Shareholders' Equity	41.11	28.77	-24.6	-14.63	-7.27
Total Liabilities & Equity	43.21	31.84	9.78	4.93	4.37
Total Debt	0.3	0.39	23.33	9.19	7.91
Net Cash (Debt)	25.8	29.25	-16.88	-7.43	-6.93
Net Cash Growth	-11.82%	-	-	-	-
Net Cash Per Share	0.40	0.65	-5.50	-2.52	-2.37
Filing Date Shares Outstanding	64.59	63.85	3.12	2.98	2.93
Total Common Shares Outstanding	64.59	63.85	3.12	2.98	2.93
Working Capital	40.59	28.53	-24.92	-15.05	-7.77
Book Value Per Share	0.64	0.45	-7.90	-4.91	-2.48
Tangible Book Value	41.11	28.77	-24.6	-14.63	-7.27
Tangible Book Value Per Share	0.64	0.45	-7.90	-4.91	-2.48
Machinery	-	0.75	0.74	0.73	0.64